Furthermore, in a syngeneic BALB/c mouse model, anti-PD-1 treatment significantly reduced tumor growth and extended survival in mice bearing 4T1-P (anti–PD-1–responsive) tumors, but not in those bearing Tyro3-OE (Tyro3-overexpressing) tumors. This evidence concerns the gene TYRO3 and neoplasm.